BioCentury
ARTICLE | Company News

Theryte, Randox Laboratories deal

March 17, 2003 8:00 AM UTC

The companies will develop early-stage cancer diagnostic tests using TheRyte’s protein biochip array technology. Randox is responsible for validating and commercializing the tests. Randox also took an...